Keeping Track: Neurology And Breakthroughs Stay In Spotlight As US FDA Approves Radicava, Imfinzi; TaiMed Submits Ibalizumab

 
• By Bridget Silverman

The latest drug development news and highlights from our Performance Tracker.

Keeping Track Feature image

More from Approvals

More from Product Reviews